Search research articles
Contact Us
Filters
Showing results (181-190 of 202) with videos related to
Page
of 21
Sort By:
Neurology
|
November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
W C Nichols, N Pankratz, D K Marek, et al.
ACS Chemical Neuroscience
|
January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists
Jeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 5, 2021
Management of Central Venous Access in Children With Intestinal Failure: A Position Paper From the NASPGHAN Intestinal Rehabilitation Special Interest Group
Danielle Wendel, Ethan A Mezoff, Vikram K Raghu, et al.
Cancer Research
|
July 1, 1982
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States
R L Comis, B F Issell, K Pittman, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2004
Novel non-peptidic neuropeptide Y Y2 receptor antagonists
Jill A Jablonowski, Wenying Chai, Xiaobing Li, et al.
Neurology
|
March 13, 2009
Variation in GIGYF2 is not associated with Parkinson disease
W C Nichols, D K Kissell, N Pankratz, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 2, 2020
Megacystis Microcolon Intestinal Hypoperistalsis Syndrome: A Case Series With Long-term Follow-up and Prolonged Survival
Krishnapriya Marangattu Prathapan, Dale E King, Vikram Kalathur Raghu, et al.
Plastic and Reconstructive Surgery. Global Open
|
March 9, 2022
A1 Pulley Tenderness as a Modification to Tenderness along the Flexor Sheath in Diagnosing Pyogenic Flexor Tenosynovitis
Robert C Siska, Amelia L Davidson, Cassandra R Driscoll, et al.
Molecular Cancer Therapeutics
|
January 30, 2004
Biological characterization of MLN944: a potent DNA binding agent
Darshan S Sappal, A Kathleen McClendon, James A Fleming, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2004
Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists
Laura C McAtee, Steven W Sutton, Dale A Rudolph, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 202) with videos related to
Sort By:
Page
of 21
Neurology
|
November 7, 2008
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
W C Nichols, N Pankratz, D K Marek, et al.
ACS Chemical Neuroscience
|
January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists
Jeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 5, 2021
Management of Central Venous Access in Children With Intestinal Failure: A Position Paper From the NASPGHAN Intestinal Rehabilitation Special Interest Group
Danielle Wendel, Ethan A Mezoff, Vikram K Raghu, et al.
Cancer Research
|
July 1, 1982
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States
R L Comis, B F Issell, K Pittman, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2004
Novel non-peptidic neuropeptide Y Y2 receptor antagonists
Jill A Jablonowski, Wenying Chai, Xiaobing Li, et al.
Neurology
|
March 13, 2009
Variation in GIGYF2 is not associated with Parkinson disease
W C Nichols, D K Kissell, N Pankratz, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 2, 2020
Megacystis Microcolon Intestinal Hypoperistalsis Syndrome: A Case Series With Long-term Follow-up and Prolonged Survival
Krishnapriya Marangattu Prathapan, Dale E King, Vikram Kalathur Raghu, et al.
Plastic and Reconstructive Surgery. Global Open
|
March 9, 2022
A1 Pulley Tenderness as a Modification to Tenderness along the Flexor Sheath in Diagnosing Pyogenic Flexor Tenosynovitis
Robert C Siska, Amelia L Davidson, Cassandra R Driscoll, et al.
Molecular Cancer Therapeutics
|
January 30, 2004
Biological characterization of MLN944: a potent DNA binding agent
Darshan S Sappal, A Kathleen McClendon, James A Fleming, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2004
Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists
Laura C McAtee, Steven W Sutton, Dale A Rudolph, et al.
Page
of 21